Illuminating tumours for attack and destruction

Next generation immuno-oncology

Discover More

OUR SCIENCE

DEVELOPING NEXT GENERATION IMMUNOTHERAPIES THAT ILLUMINATE NON-RESPONSIVE TUMOURS FOR DESTRUCTION BY THE IMMUNE SYSTEM.

Current immunotherapy approaches target the minority of tumours that are visible to the immune system. By targeting the ERAP proteases in the antigen presentation pathway Grey Wolf aims to change the neoantigen repertoire in cancer, increasing tumour visibility and extending the therapeutic benefit of immunotherapy to many more cancer patients.

Find out more >

Research Highlights

View journal articles relating to our target and posters presented at world-leading conferences.

Latest News

PROUDLY AWARDED